KLF5 and neoplasm: Clinically KLF5 has been found to play an oncogenic role where it is associated with tumor progression, aggressive clinical behavior and poor survival (Tong et al., 2006; Takagi et al., 2012; Dong et al., 2013; Li et al., 2014; Ma et al., 2017; Li et al., 2019).